Table 1.

Prevalence and correlates of lipid lowering drug use in men with documented myocardial infarction (MI) or angina

	Definite MI (n=286)			Definite angina, no MI (n=360)
	N	n	%	N	n	%
Overall prevalence
Any lipid lowering drug	286	102	36	360	84	23
Statins	286	93	33	360	78	21
Previous revascularisation
Yes	62	30	48	73	40	55
No	224	72	32	287	44	15
p value		0.018			< 0.001
Year of last diagnosis
Pre-1994	180	50	28	147	28	19
1994–1997	74	37	50	133	36	27
Post-1997	32	15	47	80	20	25
p value		< 0.001			0.26
Age at last diagnosis (years)
< 60	129	49	38	102	25	25
60–69	131	46	35	215	51	24
≥ 70	26	7	27	43	8	19
p value		0.55			0.73
Social class*
Non-manual	124	49	40	157	44	28
Manual	146	49	34	189	39	21
p value		0.31			0.15
Geographic residence
South	87	34	39	89	22	25
Scotland	37	17	46	46	11	24
North, Midlands, and Wales	162	51	31	225	51	23
p Value		0.18			0.92
Cigarette smoking status†
Current	34	11	32	46	8	17
Former	181	63	35	196	45	23
Never	60	25	42	103	28	27
p value		0.56			0.41

N, total in category; n, number within the category taking lipid lowering drugs.

*Social class not available for 16 subjects in the MI group and 20 in the angina group; †Smoking status not available for 11 subjects in the MI group and 15 in the angina group.